EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX
Clinical trial NCT03126435 · COMPLETED
Trial details
- NCT number
- NCT03126435
- Sponsor
- SynCore Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2021-07-30
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.